Nonetheless, further in-depth studies are warranted to accurately clarify the roles of NEDD4 and NEDD4L in CRC and the mechanisms of their occurrence in CRC, so that more precise targeted drugs can be developed to improve the therapeutic efficacy for CRC patients (Figure 4) (Table 1). Here, NEDD4 is linked to colorectal carcinoma.